menu
    • menu

    Company profile for Medsenic

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. To improve the life of the patient, in compliance with ethics and the rules of good biomedical research practice.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedsenicFrance Flag
    Country
    Country
    France
    Address
    Address
    11, Rue de l'académie, Strasbourg, Grand Est 67000
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medsenic.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medsenic/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
    Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

    05 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/05/2908872/0/en/Medsenic-subsidiary-of-BioSenic-SA-extends-key-patent-to-the-United-States.html

    GLOBENEWSWIRE
    05 Jul 2024
    Share Share
    Medsenic Signs New Licensing Agreements With Phebra PTY Ltd
    Medsenic Signs New Licensing Agreements With Phebra PTY Ltd

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907129/0/en/Medsenic-BioSenic-s-subsidiary-signed-a-new-set-of-licensing-and-commercialization-agreements-with-Phebra-PTY-Ltd.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Medsenic amends licence agreement with Phebra for arsenic trioxide
    Medsenic amends licence agreement with Phebra for arsenic trioxide

    30 May 2023

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/medsenic-licence-phebra-oato/

    PHARMACEUTICAL TECHNOLOGY
    30 May 2023
    Share Share
    BioSenic announces the approval and publication of the Prospectus for listing
    BioSenic announces the approval and publication of the Prospectus for listing

    08 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/08/2603612/0/en/BioSenic-announces-the-approval-and-publication-of-the-Prospectus-for-listing-and-admission-to-trading-of-the-shares-and-subscription-rights-issued-in-the-context-of-the-capital-in.html

    GLOBENEWSWIRE
    08 Feb 2023
    Share Share
    A complex fracturing at Bone brings orthopedic biotechs in reverse merger deal
    A complex fracturing at Bone brings orthopedic biotechs in reverse merger deal

    10 Aug 2022

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/complex-fracturing-bone-brings-together-inflammatory-orthopedic-biotechs-reverse-merger

    Annalee Armstrong FIERCE BIOTECH
    10 Aug 2022
    Share Share
    Bone Tx broadens portfolio by acquiring majority participation in Medsenic
    Bone Tx broadens portfolio by acquiring majority participation in Medsenic

    09 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/09/2495417/0/en/Bone-Therapeutics-to-broaden-and-derisk-therapeutic-portfolio-by-acquiring-majority-participation-in-Medsenic.html

    GLOBENEWSWIRE
    09 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search